Aldeyra Therapeutics Inc. (ALDX)
NASDAQ · Healthcare
Aldeyra Therapeutics Inc. Net Income 2020–2025
Aldeyra Therapeutics Inc. annual/quarterly net income history and growth rate from 2020 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Aldeyra Therapeutics Inc. net income for the quarter ending March 31, 2026 was -3.5 M, a 65.23% decrease year-over-year.
- Aldeyra Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -27.4 M.
- Aldeyra Therapeutics Inc. annual net income for 2025 was -33.8 M, a 39.40% decrease from 2024.
- Aldeyra Therapeutics Inc. annual net income for 2024 was -55.9 M, a 48.77% increase from 2023.
- Aldeyra Therapeutics Inc. annual net income for 2023 was -37.5 M, a 39.47% decrease from 2022.
- Aldeyra Therapeutics Inc. annual net income for 2022 was -62.0 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Aldeyra Therapeutics Inc. Net Income — FAQ
Aldeyra Therapeutics Inc. (ALDX) net income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Aldeyra Therapeutics Inc.'s net income?
Aldeyra Therapeutics Inc. (ALDX) reported net income of -$34M for fiscal 2025.
Where can I see ALDX's net income history?
The chart and table above show Aldeyra Therapeutics Inc.'s net income by year and by quarter, including the growth rate.